Remote Endarterectomy and Endovascular Treatments in Patients With the Femoral Artery Occlusive Disease
Remote Endarterectomy and Endovascular Treatments in Patients With the Femoral Artery Occlusive Disease
Comparison of two methods for revascularization of the superficial femoral artery: remote
 endarterectomy vs. stenting of the superficial femoral artery cin patients with
 steno-occlusive lesion of the femoro-popliteal segment of TASC C, D
Reported local percutaneous angioplasty and stenosis of femoral popliteal arteries indicate
 that the primary technical and clinical success above 95%. The technical success of
 recanalization of long occlusions femoral arteries less than 80%. Improvement of endovascular
 equipment designed for the treatment of total occlusions, increases the technical success of
 recanalization. The materials of the TASC II summarizes the results of several large studies
 that presented data on the operated segment artery patency at 56-73,7% within 2 years of
 observation. An alternative method of revascularization own femoral artery is remote
 endarterectomy. The two-year primary patency at remote endarterectomy is 86% (Moll F.L., Iio
 G.H. Closed superficial femoral artery endarterectomy: a 2-year follow up. Cardiovasc Surg.
 1997; 5: 398-400). Primary assisted patency for 33 months 88% (Rosenthal D, Martin JD,
 Schubart PJ, Wellons ED. Remote. superﬁcial femoral artery endarterectomy. J Cardiovasc Surg.
 (Torino) 2004; 45: 185-192). The length of the occlusion is not a limitation to the use of
 remote endarterectomy. Primary patency at 31 months was 60%.
Inclusion Criteria:

 -  Patients with occlusive lesions of C and D type femoral artery and with chronic lower
 limb ischemia (II-IV degree by Fontaine, 4-6 degree by Rutherford)

 -  Patients who consented to participate in this study.

 Exclusion Criteria:

 -  Chronic heart failure of III-IV functional class by NYHA classification.

 -  Decompensated chronic "pulmonary" heart

 -  Severe hepatic or renal failure (bilirubin> 35 mmol / l, glomerular filtration rate
 <60 mL / min);

 -  Polyvalent drug allergy

 -  Cancer in the terminal stage with a life expectancy less than 6 months;

 -  Acute ischemic

 -  Expressed aortic calcification tolerant to angioplasty

 -  Patients with significant common femoral artery lesion

 -  Patient refusal to participate or continue to participate in the study